Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Microcap Kitchen Canadian Stocks -- Ignore unavailable to you. Want to Upgrade?

To: Clark Kent who wrote (49133)	4/13/2020 11:37:31 AM
From: kidl	Read Replies (3) \| Respond to of 49402

PMED ... A great example of how the MC market operates as in never let facts get in the way of a good trade. My apologies to your gut. GSI ... A rare exception to the above. Latest update from SmallCaps: smallcaps.us

To: Clark Kent who wrote (49133)	4/22/2020 10:22:16 AM
From: Clark Kent	Respond to of 49402

PMED.C I can't chase this one after missing such a huge move up. However I continue to watch it and dream of what could have been. Test works it goes up...test fails it goes down. Predictmedix begins impairment testing pilot 2020-04-22 08:17 ET - News Release Dr. Rahul Kushwah reports PREDICTMEDIX INC. ANNOUNCES LAUNCH OF A PILOT WITH HINDALCO INDUSTRIES LTD FOR ITS IMPAIRMENT DETECTION AI TECHNOLOGY Predictmedix Inc. is launching a pilot of its cannabis and alcohol impairment detection technology with Hindalco Industries Ltd. Hindalco, like many companies, recognize the impact of cannabis and alcohol impairment on their workforce. A National Institute on Drug Abuse Study found that employees who tested positive for cannabis had 55% more industrial accidents, 85% more injuries and 75% greater absenteeism. The dwiresourcecenter.org notes that employees using alcohol or drugs at work cost employers on average $7,000 per year. The Predictmedix pilot will be carried out at Hindalco's manufacturing unit, Aditya Aluminum which is a 900 Megawatt captive power plant. The pilot is expected to begin within the next two weeks and will utilize Predictmedix's proprietary AI powered impairment detection technology (patent pending) to identify cannabis and alcohol impairment. The pilot if uninterrupted, is expected to be completed within a 12-week period. Mr. Kailash Pandey, Unit Head of Hindalco commented, "Industry 4.0 has immense potential and AI is its fundamental driver. We are excited to work with the frontier technology for better safety and compliance at our plants." Predictmedix has been carrying out an independent impairment study for cannabis and alcohol with over 3,000 participants using its proprietary AI technology. With the positive outcomes achieved to date, the company has been able to advance to the pilot stage with Hindalco. "The beginning of this pilot with Hindalco is a significant milestone for our impairment detection technology as it brings us a step closer toward commercialization and the full market launch of our technology for the workplace", said Dr. Rahul Kushwah, COO of Predictmedix.